Pre-Clinical Trial Results

Controlled and prolonged elution kinetics and efficient drug transfer to arteries.

MiStent SES's unique coating formulation and technology delivers a controlled and sustained release of a drug from a fully-absorbable coating. This differentiated method of target drug delivery has already shown promising results related to safety and prolonged elution kinetics in pre-clinical porcine trials.

[N.B.: Not included here - porcine coronary artery implants cross-sections]

Clinical significance in humans is unknown.